Article

Osteoarthritis Patients Should Get Moving

People with osteoarthritis are more likely to be able to walk quickly if they lead physically active lives.

Research from Northwestern University Feinberg School of Medicine demonstrates that people with osteoarthritis are more likely to be able to walk quickly when needed if they lead physically active lives.

"The more active people are, the faster they can walk," Dorothy Dunlop, associate professor of medicine at Northwestern University Feinberg School of Medicine and lead author of the study, said in a press release. "This is strong evidence that even a small increase in activity is related to better walking function. The bar for improvement isn't that high. This should motivate people to get moving, even if they have pain or stiffness."

The study is published in the January issue of Arthritis & Rheumatism.

Knee osteoarthritis is a leading cause of disability in adults. As it progresses, it can threaten an individual's ability to live independently. Maintaining function and independent living is an important goal for the more than 27 million US adults with osteoarthritis.

"This study provides encouragement for people who are on the low end of the physical activity spectrum to increase their physical activity," Dunlop, a health services researcher who also is with the Institute for Healthcare Studies at Feinberg, said. "You don't have to be in the top physical activity group before you start to see improvements in your walking speed."

Physical activity produces big benefits for people with knee osteoarthritis. In addition to improving the ability to walk, physical activity also promotes healthy joint cartilage and reduces pain, depression and fatigue, Dunlop noted.

Federal guidelines recommend adults with arthritis should participate in at least 2.5 hours a week of moderate intensity, low-impact activity in sessions lasting 10 minutes or more. Even if people can't meet these levels, Dunlop said they should be as physically active as possible.

The Osteoarthritis Initiative, an observational study, surveyed 2,500 participants with knee osteoarthritis. Participants filled out self-reported questionnaires about their physical activity at sites in Columbus, Ohio, Baltimore, Md., Providence, R.I., and Pittsburgh, Pa.

Researchers divided participants into four physical activity groups, from lowest to highest, using a general activity score. In the lowest physical activity group, less than half, or 49%, walked fast enough to cross the street before the light changed. (Traffic lights generally allow a walking speed of four feet per second.) In the next three higher physical activity groups, 63%, 71% and 81%, respectively, walked fast enough to cross the street.

The study was sponsored by the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Source: Northwestern University--Will you share this information with your osteoarthritis patients? How will the information impact the way you treat your OA patients? Leave a comment.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.